Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation

Ben F. M. Wijnen*, Edwin J. M. Oberje, Silvia M. A. A. Evers, Jan M. Prins, Hans-Erik Nobel, Cees van Nieuwkoop, Jan Veenstra, Frank J. Pijnappel, Frank P. Kroon, Laura van Zonneveld, Astrid G. W. van Hulzen, Marjolein van Broekhuizen, Marijn de Bruin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)658-667
Number of pages10
JournalClinical Infectious Diseases
Volume68
Issue number4
DOIs
Publication statusPublished - 15 Feb 2019

Keywords

  • adherence
  • intervention
  • HIV/AIDS
  • cost-effectiveness
  • cost-utility
  • ACTIVE ANTIRETROVIRAL THERAPY
  • HIV-INFECTED PATIENTS
  • FORM HEALTH SURVEY
  • MEDICATION ADHERENCE
  • TREATMENT OUTCOMES
  • VIRAL LOAD
  • INTERVENTIONS
  • QUESTIONNAIRE
  • NONADHERENCE
  • MULTICENTER

Cite this

Wijnen, B. F. M., Oberje, E. J. M., Evers, S. M. A. A., Prins, J. M., Nobel, H-E., van Nieuwkoop, C., Veenstra, J., Pijnappel, F. J., Kroon, F. P., van Zonneveld, L., van Hulzen, A. G. W., van Broekhuizen, M., & de Bruin, M. (2019). Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation. Clinical Infectious Diseases, 68(4), 658-667. https://doi.org/10.1093/cid/ciy553